Back to top

Image: Bigstock

Idera Pharmaceuticals in Focus: Stock Adds 8.8% in Session

Read MoreHide Full Article

Idera Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume, leading to far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 23% since Aug 31.

The company has not seen any estimate revision in the past month and its Zacks Consensus Estimate hasn’t been in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Idera Pharmaceuticals currently carries a Zacks Rank #3 (Hold), while its Earnings ESP is 0.00%.

A better-ranked stock in the pharmaceuticals industry is ANI Pharmaceuticals, Inc. (ANIP - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is IDRA going up? Or down? Predict to see what others think: Up or Down

Confidential from Zacks

Beyond this Tale of the Tape, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


ANI Pharmaceuticals, Inc. (ANIP) - free report >>

Published in